In this episode:

• In the patient with newly diagnosed T2DM without micro or macrovascular complications, achieving good glycaemic control is important and this together with an eye to avoiding weight gain and hypoglycaemia will drive your choice of a second-line agent
•  For those at very high risk of having or those who have existing vascular disease, choosing a disease-modifying agent is important
• We have to proactively avoid clinical inertia in our prescribing habits and become familiar with newer classes of agents and use them
• Dr Anita Sharma gives us a clear guide as to which agent is a better choice as second and third line in particular clinical scenarios

Host: Dr David Lim, GP and Medical Educator

Total time: 44 mins

Guest: Dr Anita Sharma, GP and Practice Principal